🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The PACIFIC study established the standard of care for immunotherapy consol...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07235306
Treatments Being Tested
This is a prospective, multi-center, single-arm, phase 2 study aiming to as...
Status
Recruiting
Location
Jun Feng Liu
Start Date
2022-05-01
Trial ID
NCT05241028
Treatments Being Tested
This is a Phase II, single-Arm, prospective study of neoadjuvant Ensartinib...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2022-08-17
Trial ID
NCT05380024
Treatments Being Tested
The main objective of this study is to evaluate the Effect of Food on the P...
Status
Completed
Location
The 1st Phase Clinical Research Center of the Second Affiliated Hospital of Zhejiang University Medical College
Start Date
2018-03-12
Trial ID
NCT03510611
Treatments Being Tested
The purpose of this study is to test the effects of the study drug, ensarti...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Monmouth
Start Date
2018-01-10
Trial ID
NCT03420508
Treatments Being Tested
This is the first human study to use X-396 (ensartinib), a drug being devel...
Status
Completed
Location
City of Hope National Med Ctr
Start Date
2012-06
Trial ID
NCT01625234
Treatments Being Tested
To assess efficacy and safety of oral X-396 (Ensartinib) capsule in Chinese...
Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy Of Medical Sciences, Shenzhen Center
Start Date
2019-04-12
Trial ID
NCT03753685
Treatments Being Tested
To explore the efficacy and safety of ensartinib on adjuvant therapy guided...
Status
Not Yet Recruiting
Location
Beijing cancer hospital
Start Date
2025-01-15
Trial ID
NCT06780839
Treatments Being Tested
In lung cancer, ensartinib is effective in improving the prognosis of ALK p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-28
Trial ID
NCT06762327
Treatments Being Tested
After the use of second-generation ALK-TKI drug resistance, about 50% of ti...
Status
Unknown
Location
Sun Yat-sen University
Start Date
2021-12-01
Trial ID
NCT05178511
Treatments Being Tested